A citation-based method for searching scientific literature

Saniya Tandon, Salma Ayis, David Hopkins, Seeromanie Harding, Marietta Stadler. Diabetes Obes Metab 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
71
100


Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.
Kamlesh Khunti, Melanie Davies, Azeem Majeed, Brian Larsen Thorsted, Michael Lyng Wolden, Sanjoy K Paul. Diabetes Care 2015
173
100

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Thomas F Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard. Diabetes Obes Metab 2020
5
100

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.
Kevan C Herold, Stephen E Gitelman, Mario R Ehlers, Peter A Gottlieb, Carla J Greenbaum, William Hagopian, Karen D Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard,[...]. Diabetes 2013
183
100

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
Sabita S Soedamah-Muthu, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun. Diabetes Care 2006
235
100



Autoreactive T cells in type 1 diabetes.
Alberto Pugliese. J Clin Invest 2017
118
100

Autoimmune aspects of type 2 diabetes mellitus - a mini-review.
Bianca K Itariu, Thomas M Stulnig. Gerontology 2014
52
100

Targeting Interleukin-6 Signaling in Clinic.
Sujin Kang, Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto. Immunity 2019
205
100

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
697
100

How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited.
Mark A Atkinson, Jeffrey A Bluestone, George S Eisenbarth, Matthias Hebrok, Kevan C Herold, Domenico Accili, Massimo Pietropaolo, Peter R Arvan, Matthias Von Herrath, Dorene S Markel,[...]. Diabetes 2011
135
100

Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial.
Ryotaro Bouchi, Yujiro Nakano, Tatsuya Fukuda, Takato Takeuchi, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa. Endocr J 2017
42
100


SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W Mahaffey, David M Charytan, David C Wheeler, Clare Arnott,[...]. Lancet Diabetes Endocrinol 2019
198
100

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
John A Todd, Marina Evangelou, Antony J Cutler, Marcin L Pekalski, Neil M Walker, Helen E Stevens, Linsey Porter, Deborah J Smyth, Daniel B Rainbow, Ricardo C Ferreira,[...]. PLoS Med 2016
61
100

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.
Jordan Rowlands, Julian Heng, Philip Newsholme, Rodrigo Carlessi. Front Endocrinol (Lausanne) 2018
61
100

The challenge of modulating β-cell autoimmunity in type 1 diabetes.
Mark A Atkinson, Bart O Roep, Amanda Posgai, Daniel C S Wheeler, Mark Peakman. Lancet Diabetes Endocrinol 2019
49
100

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, Thomas W Donner, Emanuele Bosi, Bruce W Bode, Paolo Pozzilli. Diabetes Care 2014
67
100

The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes.
Christine Bender, Teresa Rodriguez-Calvo, Natalie Amirian, Ken T Coppieters, Matthias G von Herrath. Sci Adv 2020
14
100

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Fred Whitehouse, Davida F Kruger, Mark Fineman, Larry Shen, James A Ruggles, David G Maggs, Christian Weyer, Orville G Kolterman. Diabetes Care 2002
185
100

Concordance for islet autoimmunity among monozygotic twins.
Maria J Redondo, Joy Jeffrey, Pamela R Fain, George S Eisenbarth, Tihamer Orban. N Engl J Med 2008
146
100


Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
95
100

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.
Anette-Gabriele Ziegler, Peter Achenbach, Reinhard Berner, Kristina Casteels, Thomas Danne, Melanie Gündert, Joerg Hasford, Verena Sophia Hoffmann, Olga Kordonouri, Karin Lange,[...]. BMJ Open 2019
19
100

Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Jenny Aurielle B Babon, Megan E DeNicola, David M Blodgett, Inne Crèvecoeur, Thomas S Buttrick, René Maehr, Rita Bottino, Ali Naji, John Kaddis, Wassim Elyaman,[...]. Nat Med 2016
156
100

Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.
William Hagopian, Robert J Ferry, Nicole Sherry, David Carlin, Ezio Bonvini, Syd Johnson, Kathryn E Stein, Scott Koenig, Anastasia G Daifotis, Kevan C Herold,[...]. Diabetes 2013
115
100

An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.
Liliane Khoryati, Minh Nguyet Pham, McKenna Sherve, Swarnima Kumari, Kevin Cook, Josh Pearson, Marika Bogdani, Daniel J Campbell, Marc A Gavin. Sci Immunol 2020
7
100

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
Araz Rawshani, Naveed Sattar, Stefan Franzén, Aidin Rawshani, Andrew T Hattersley, Ann-Marie Svensson, Björn Eliasson, Soffia Gudbjörnsdottir. Lancet 2018
189
100

SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution.
Joseph I Wolfsdorf, Robert E Ratner. Diabetes Care 2019
11
100

Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
Jeffrey P Krischer, Desmond A Schatz, Brian Bundy, Jay S Skyler, Carla J Greenbaum. JAMA 2017
65
100

Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine.
Bart O Roep, Daniel C S Wheeler, Mark Peakman. Lancet Diabetes Endocrinol 2019
45
100


Current progress in stem cell therapy for type 1 diabetes mellitus.
Shuai Chen, Kechen Du, Chunlin Zou. Stem Cell Res Ther 2020
7
100

Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.
Rachel G Miller, Aaron M Secrest, Ravi K Sharma, Thomas J Songer, Trevor J Orchard. Diabetes 2012
143
100

Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Christopher C Patterson, Suvi Karuranga, Paraskevi Salpea, Pouya Saeedi, Gisela Dahlquist, Gyula Soltesz, Graham D Ogle. Diabetes Res Clin Pract 2019
68
100

Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
Somayeh Sabouri, Mehdi A Benkahla, William B Kiosses, Teresa Rodriguez-Calvo, Jose Zapardiel-Gonzalo, Ericka Castillo, Matthias G von Herrath. J Autoimmun 2020
4
100

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).
Bart O Roep, Sofia Thomaidou, René van Tienhoven, Arnaud Zaldumbide. Nat Rev Endocrinol 2021
22
100

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
134
100

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
87
100

β cell ER stress and the implications for immunogenicity in type 1 diabetes.
Meghan L Marré, Eddie A James, Jon D Piganelli. Front Cell Dev Biol 2015
57
100

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.
Stephen E Gitelman, Peter A Gottlieb, Mark R Rigby, Eric I Felner, Steven M Willi, Lynda K Fisher, Antoinette Moran, Michael Gottschalk, Wayne V Moore, Ashley Pinckney,[...]. Lancet Diabetes Endocrinol 2013
84
100

Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.
John R Petrie, Naveed Sattar. Circulation 2019
7
100

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Lancet 2011
347
100

Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
Amelia K Linnemann, Joshua C Neuman, Therese J Battiola, Jaclyn A Wisinski, Michelle E Kimple, Dawn Belt Davis. Mol Endocrinol 2015
36
100

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
100

The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
Ionut Bebu, Barbara H Braffett, Rodica Pop-Busui, Trevor J Orchard, David M Nathan, John M Lachin. Diabetologia 2017
36
100

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.
Bernt Johan von Scholten, Frederik Persson, Signe Rosenlund, Jesper Eugen-Olsen, Tomasz Pielak, Jens Faber, Tine W Hansen, Peter Rossing. Diabetes Obes Metab 2017
27
100

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.
Helen M McGuire, Stacey Walters, Alexis Vogelzang, Carol M Y Lee, Kylie E Webster, Jonathan Sprent, Daniel Christ, Shane Grey, Cecile King. Diabetes 2011
63
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.